ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

22,680Medicare Part D Prescriptions Filled, Including Refills

Rank: 15 out of 2680

$1.27M Total Retail Price of All Prescriptions

Rank: 28 out of 2680

828 Patients Receiving at Least One Drug in Part D
62%Patients 65 Years and Older
86% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 828 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

14% of this provider’s 828 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

3% of this provider’s 15,378 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
OMEPRAZOLE 929 575 1 2
AMLODIPINE BESYLATE 844 652 2 3
METFORMIN HCL 761 517 3 6
SIMVASTATIN 635 474 4 1
LISINOPRIL 599 462 5 5
IBUPROFEN 569 245 6 63
ZOLPIDEM TARTRATE 520 279 7 17
NEXIUM 435 241 8 19
HYDROCHLOROTHIAZIDE 427 327 9 9
CRESTOR 388 237 10 15
ALENDRONATE SODIUM 312 255 11 20
METOPROLOL TARTRATE 296 226 12 8
JANUVIA 291 223 13 34
MECLIZINE HCL 262 159 14 105
TAMSULOSIN HCL 261 183 15 25
NAMENDA 256 228 16 43
GLYBURIDE 245 197 R 17 66
NABUMETONE 242 138 18 249
DONEPEZIL HCL 231 201 19 28
LOVAZA 229 143 20 47
NAPROXEN 227 95 21 91
ATENOLOL 225 176 22 14
NIFEDIPINE ER 220 185 23 73
MELOXICAM 218 162 24 50
LISINOPRIL-HYDROCHLOROTHIAZIDE 217 113 25 31
FUROSEMIDE 216 187 26 7
PRAVASTATIN SODIUM 206 134 27 16
GABAPENTIN 204 115 28 21
LOVASTATIN 202 199 29 37
AMLODIPINE BESYLATE-BENAZEPRIL 200 167 30 58
LOSARTAN POTASSIUM 189 135 31 18
ENALAPRIL MALEATE 189 145 31 24
METOPROLOL SUCCINATE 189 143 31 11
DIOVAN HCT 187 130 34 54
FLUTICASONE PROPIONATE 184 91 35 38
HYDROCODONE-ACETAMINOPHEN 181 59 S3 36 13
DICLOFENAC SODIUM 168 94 37 147
CARVEDILOL 164 127 38 27
LEVOTHYROXINE SODIUM 162 123 39 4
LOSARTAN-HYDROCHLOROTHIAZIDE 154 101 40 46
ATORVASTATIN CALCIUM 150 101 41 10
DIOVAN 148 117 42 26
FINASTERIDE 143 110 43 80
PROAIR HFA 140 80 44 52
AZITHROMYCIN 139 65 45 40
BUMETANIDE 134 119 46 225
ETODOLAC 131 71 47 310
FENOFIBRATE 124 45 48 77
CLOTRIMAZOLE-BETAMETHASONE 124 47 48 109
ADVAIR DISKUS 122 65 50 32
SINGULAIR 121 81 51 64
NYSTATIN-TRIAMCINOLONE 121 55 51 140
GLYBURIDE-METFORMIN HCL 120 92 R 53 96
AMMONIUM LACTATE 118 68 54 118
RANITIDINE HCL 115 79 55 35
LANSOPRAZOLE 114 94 56 121
VOLTAREN 112 72 57 103
ALCOHOL PREP PADS 111 77 58 259
CELEBREX 110 46 59 75
PLAVIX 110 87 59 41
SINGLE USE SWAB 105 60 61 196
WARFARIN SODIUM 104 95 62 12
RAMIPRIL 101 70 63 49
LEVETIRACETAM 101 86 63 94
POTASSIUM CHLORIDE 101 64 63 29
QUETIAPINE FUMARATE 96 96 66 72
TRAMADOL HCL-ACETAMINOPHEN 96 67 66 167
BETAMETHASONE DIPROPIONATE 94 57 68 258
CYCLOBENZAPRINE HCL 94 13 R 68 95
LANTUS 93 76 70 70
AMITRIPTYLINE HCL 92 59 R 71 113
ACETAMINOPHEN-CODEINE 90 27 S3 72 156
VENTOLIN HFA 86 58 73 61
POLYETHYLENE GLYCOL 3350 84 79 74 55
ALCOHOL SWABS 82 41 75 181
QUINAPRIL HCL 80 51 76 79
CLOPIDOGREL 79 67 77 30
FAMOTIDINE 78 65 78 65
GLIPIZIDE XL 78 70 78 87
LYRICA 78 35 78 107
SERTRALINE HCL 77 44 81 23
PATANOL 76 53 82 239
NYSTATIN 70 53 83 160
ISOSORBIDE MONONITRATE ER 70 64 83 57
DILTIAZEM 24HR CD 68 60 85 148
CARBIDOPA-LEVODOPA 68 68 85 88
DILTIAZEM 24HR ER 66 59 87 131
DOXEPIN HCL 65 48 88 397
ZETIA 65 35 88 69
LIPITOR 64 42 90 78
PAROXETINE HCL 64 39 90 62
GLIMEPIRIDE 64 55 90 51
INSULIN SYRINGE 60 45 93 187
TRAZODONE HCL 59 48 94 60
SYMBICORT 58 38 95 114
CIPROFLOXACIN HCL 58 32 95 85
BISOPROLOL-HYDROCHLOROTHIAZIDE 57 33 97 117
MONTELUKAST SODIUM 57 32 97 134
TRAMADOL HCL 55 27 99 33
JANUMET 54 18 100 83
SPIRIVA 54 51 100 36
FOSINOPRIL SODIUM 54 42 100 198
NIFEDICAL XL 53 48 103 289
LANTUS SOLOSTAR 52 27 104 68
ESCITALOPRAM OXALATE 50 45 105 82
BUSPIRONE HCL 50 37 105 174
PROCTOZONE-HC 50 0 105 280
RISPERIDONE 50 35 105 67
FELODIPINE ER 50 13 105 216
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 22, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.